Randomized, dose-escalation study of the p38α MAPK inhibitor SCIO-469 in patients with myelodysplastic syndrome

L. Sokol, Larry Cripe, H. Kantarjian, M. A. Sekeres, S. Parmar, P. Greenberg, S. L. Goldberg, V. Bhushan, J. Shammo, R. Hohl, A. Verma, G. Garcia-Manero, Y. P. Li, A. Lowe, J. Zhu, A. F. List

Research output: Contribution to journal › Article

19 Citations (Scopus)
Original languageEnglish
Pages (from-to)977-980
Number of pages4
JournalLeukemia
Volume27
Issue number4
DOIs
StatePublished - Apr 2013

Fingerprint

Drug Dose Response Relationship
Mitogen-Activated Protein Kinase 14
Indoles
Myelodysplastic Syndromes
Protein Kinase Inhibitors
SCIO-469

ASJC Scopus subject areas

  • Hematology
  • Cancer Research
  • Anesthesiology and Pain Medicine

Cite this

Sokol, L., Cripe, L., Kantarjian, H., Sekeres, M. A., Parmar, S., Greenberg, P., ... List, A. F. (2013). Randomized, dose-escalation study of the p38α MAPK inhibitor SCIO-469 in patients with myelodysplastic syndrome. Leukemia, 27(4), 977-980. https://doi.org/10.1038/leu.2012.264

Randomized, dose-escalation study of the p38α MAPK inhibitor SCIO-469 in patients with myelodysplastic syndrome. / Sokol, L.; Cripe, Larry; Kantarjian, H.; Sekeres, M. A.; Parmar, S.; Greenberg, P.; Goldberg, S. L.; Bhushan, V.; Shammo, J.; Hohl, R.; Verma, A.; Garcia-Manero, G.; Li, Y. P.; Lowe, A.; Zhu, J.; List, A. F.

In: Leukemia, Vol. 27, No. 4, 04.2013, p. 977-980.

Research output: Contribution to journal › Article

Sokol, L, Cripe, L, Kantarjian, H, Sekeres, MA, Parmar, S, Greenberg, P, Goldberg, SL, Bhushan, V, Shammo, J, Hohl, R, Verma, A, Garcia-Manero, G, Li, YP, Lowe, A, Zhu, J & List, AF 2013, 'Randomized, dose-escalation study of the p38α MAPK inhibitor SCIO-469 in patients with myelodysplastic syndrome', Leukemia, vol. 27, no. 4, pp. 977-980. https://doi.org/10.1038/leu.2012.264
Sokol L, Cripe L, Kantarjian H, Sekeres MA, Parmar S, Greenberg P et al. Randomized, dose-escalation study of the p38α MAPK inhibitor SCIO-469 in patients with myelodysplastic syndrome. Leukemia. 2013 Apr;27(4):977-980. https://doi.org/10.1038/leu.2012.264
Sokol, L. ; Cripe, Larry ; Kantarjian, H. ; Sekeres, M. A. ; Parmar, S. ; Greenberg, P. ; Goldberg, S. L. ; Bhushan, V. ; Shammo, J. ; Hohl, R. ; Verma, A. ; Garcia-Manero, G. ; Li, Y. P. ; Lowe, A. ; Zhu, J. ; List, A. F. / Randomized, dose-escalation study of the p38α MAPK inhibitor SCIO-469 in patients with myelodysplastic syndrome. In: Leukemia. 2013 ; Vol. 27, No. 4. pp. 977-980.
@article{07da50bb990b42c1902c004aeb9c8472,
title = "Randomized, dose-escalation study of the p38α MAPK inhibitor SCIO-469 in patients with myelodysplastic syndrome",
author = "L. Sokol and Larry Cripe and H. Kantarjian and Sekeres, {M. A.} and S. Parmar and P. Greenberg and Goldberg, {S. L.} and V. Bhushan and J. Shammo and R. Hohl and A. Verma and G. Garcia-Manero and Li, {Y. P.} and A. Lowe and J. Zhu and List, {A. F.}",
year = "2013",
month = "4",
doi = "10.1038/leu.2012.264",
language = "English",
volume = "27",
pages = "977--980",
journal = "Leukemia",
issn = "0887-6924",
publisher = "Nature Publishing Group",
number = "4",

}

TY - JOUR

T1 - Randomized, dose-escalation study of the p38α MAPK inhibitor SCIO-469 in patients with myelodysplastic syndrome

AU - Sokol, L.

AU - Cripe, Larry

AU - Kantarjian, H.

AU - Sekeres, M. A.

AU - Parmar, S.

AU - Greenberg, P.

AU - Goldberg, S. L.

AU - Bhushan, V.

AU - Shammo, J.

AU - Hohl, R.

AU - Verma, A.

AU - Garcia-Manero, G.

AU - Li, Y. P.

AU - Lowe, A.

AU - Zhu, J.

AU - List, A. F.

PY - 2013/4

Y1 - 2013/4

UR - http://www.scopus.com/inward/record.url?scp=84876114118&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876114118&partnerID=8YFLogxK

U2 - 10.1038/leu.2012.264

DO - 10.1038/leu.2012.264

M3 - Article

VL - 27

SP - 977

EP - 980

JO - Leukemia

JF - Leukemia

SN - 0887-6924

IS - 4

ER -

Access to Document